AI can accelerate R&D, but every gain in efficiency depends on whether your tools can find the right imaging data without breaking security and compliance mandates. With the FDA now counting early-phase imaging as evidence for approval, teams need data infrastructure that keeps pace with AI while holding up to regulatory scrutiny.
Watch this brief summary of a session we held at Flywheel’s Annual Imaging Ecosystem Summit: Building the Infrastructure for Better R&D. Reach out if you’d like to learn more.
